Differentiating Prostatitis from UTI in Men Over 65
In men over 65, differentiate prostatitis from simple UTI by assessing for prostatic tenderness on digital rectal examination (DRE), evaluating symptom duration and character, and recognizing that prostatitis typically presents with less severe urinalysis abnormalities than UTI.
Clinical Assessment Algorithm
Step 1: History and Physical Examination
Key discriminating features:
Symptom onset and duration: Acute bacterial prostatitis (ABP) presents with acute onset of fever, chills, and systemic symptoms alongside urinary complaints 1. Simple UTI may present with more isolated urinary symptoms or atypical presentations in older adults (confusion, functional decline, falls) 2.
Pain characteristics: Prostatitis causes pelvic, perineal, or suprapubic pain, often with pain on ejaculation 3. Simple cystitis causes primarily dysuria and suprapubic discomfort.
Digital rectal examination (DRE): A tender, boggy prostate on DRE strongly suggests acute bacterial prostatitis 1, 3. However, only a minority of prostatitis cases demonstrate prostatic tenderness—in one ED study, only 6 of 77 prostatitis cases (7.8%) had tender prostates 4. Do not perform prostatic massage in suspected ABP 1.
Step 2: Laboratory Differentiation
Urinalysis patterns differ significantly:
Men with prostatitis demonstrate less severe urinalysis abnormalities compared to simple UTI 4:
- Lower leukocyte esterase (0.9+ vs 2.3+)
- Lower white blood cell counts (31.6/HPF vs 57.6/HPF)
- Less nitrite positivity (8.0% vs 21.4%)
- Less bacteriuria (0.9+ vs 1.8+)
Critical diagnostic steps:
- Obtain midstream urine culture before antibiotics to guide therapy 1
- Blood cultures if fever or systemic symptoms present 1
- Avoid routine PSA testing immediately after suspected infection—PSA elevates non-specifically with prostatitis and can remain elevated for up to 3 months post-infection 5, 6. PSA elevation occurs in 83% of men with febrile UTI regardless of clinical prostatic tenderness 5.
Step 3: Consider Imaging
Transrectal ultrasound (TRUS) should be performed in selected cases to rule out prostatic abscess, particularly if fever persists despite appropriate antibiotics 1. Prostatic involvement is common even without clinical tenderness—prostate volume decreases by 31% after treatment in men with febrile UTI, indicating frequent subclinical prostatic involvement 5.
Treatment Duration as Diagnostic Clue
Treatment duration requirements help confirm the diagnosis retrospectively:
- Simple UTI/cystitis: 7 days (or up to 14 days in men when prostatitis cannot be excluded) 1
- Acute bacterial prostatitis: 2-4 weeks of fluoroquinolones or appropriate antibiotics 3, 7
- Chronic bacterial prostatitis: Minimum 4-12 weeks 1, 7
Common Pitfalls
Over-reliance on urinalysis: High asymptomatic bacteriuria (ABU) prevalence in older men means bacteriuria alone doesn't confirm UTI 1, 2. Dipstick specificity is only 20-70% in elderly patients 2.
Assuming all febrile UTIs in men are prostatitis: While prostatic involvement is common (83% show PSA elevation) 5, not all require extended therapy. Base treatment duration on clinical severity and response.
Missing atypical presentations: Older men frequently present with altered mental status, falls, or functional decline rather than classic UTI symptoms 2.
Inadequate microbiological workup: For chronic bacterial prostatitis, perform the Meares-Stamey 2- or 4-glass test to confirm prostatic localization of infection 1, 7. Consider testing for atypical pathogens (Chlamydia, Mycoplasma) in chronic cases 1.
Practical Decision Framework
Prescribe antibiotics for prostatitis (extended duration) if:
- Tender prostate on DRE, OR
- Fever/systemic symptoms with urinary complaints, OR
- Recurrent UTIs from same organism (suggests chronic bacterial prostatitis)
Treat as simple UTI (7-14 days) if:
- No prostatic tenderness
- Isolated lower urinary tract symptoms
- No fever or systemic symptoms
- First episode
When uncertain: In men over 65 with febrile UTI, treat for 14 days initially to cover potential prostatic involvement 1, then reassess based on clinical response and culture results.